Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic Effects of Continuous Intravenous S(+)-ketamine in Septic Shock Patients on Mechanical Ventilation
ChiCTR2200058199Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Soochow University
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in septic shock (2 arms), sponsored by The Second Affiliated Hospital of Soochow University. Primary endpoint: Dose of norepinephrine. Planned start Mar 2022; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
septic shock
Beyond the preview
Go deeper on ChiCTR2200058199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200058199.